当前位置:
X-MOL 学术
›
Ophthalmology
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report
Ophthalmology ( IF 13.1 ) Pub Date : 2024-03-16 , DOI: 10.1016/j.ophtha.2024.03.013 Xiu Juan Zhang , Yuzhou Zhang , Benjamin H.K. Yip , Ka Wai Kam , Fangyao Tang , Xiangtian Ling , Mandy P.H. Ng , Alvin L. Young , Pei-Chang Wu , Clement C. Tham , Li Jia Chen , Chi Pui Pang , Jason C. Yam
Ophthalmology ( IF 13.1 ) Pub Date : 2024-03-16 , DOI: 10.1016/j.ophtha.2024.03.013 Xiu Juan Zhang , Yuzhou Zhang , Benjamin H.K. Yip , Ka Wai Kam , Fangyao Tang , Xiangtian Ling , Mandy P.H. Ng , Alvin L. Young , Pei-Chang Wu , Clement C. Tham , Li Jia Chen , Chi Pui Pang , Jason C. Yam
To evaluate (1) the long-term efficacy of low-concentration atropine over 5 years, (2) the proportion of children requiring re-treatment and associated factors, and (3) the efficacy of pro re nata (PRN) re-treatment using 0.05% atropine from years 3 to 5.
中文翻译:
低浓度阿托品治疗近视加深 (LAMP) 研究的五年临床试验:4 期报告
评估 (1) 低浓度阿托品 5 年的长期疗效,(2) 需要再治疗的儿童比例和相关因素,以及 (3) 使用 0.05% 阿托品进行 pro re nata (PRN) 再治疗的疗效从 3 岁到 5 岁。
更新日期:2024-03-16
中文翻译:
低浓度阿托品治疗近视加深 (LAMP) 研究的五年临床试验:4 期报告
评估 (1) 低浓度阿托品 5 年的长期疗效,(2) 需要再治疗的儿童比例和相关因素,以及 (3) 使用 0.05% 阿托品进行 pro re nata (PRN) 再治疗的疗效从 3 岁到 5 岁。